Institutional Fund
Sector Gamma As
Oslo, NorwayCIK 14753735 filings on record
Portfolio Value
$423.49M
Q1 2026
Holdings
42
Reported positions
New Buys
11
Opened this quarter
QoQ Change
-3.5%
from $438.71M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Bristol-Myers Squibb Co11.9%
- Merck & Co Inc7.4%
- Pfizer Inc7.2%
- Medtronic PLC5.7%
- Incyte Corp4.5%
- Amgen Inc3.9%
- Other59.4%
Portfolio Holdings
42 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Bristol-Myers Squibb Co | 827.9K | $50.21M | 11.9% | +81.9K | Added |
| 2 | Merck & Co Inc | 260.3K | $31.32M | 7.4% | −103.3K | Reduced |
| 3 | Pfizer Inc | 1.09M | $30.65M | 7.2% | +231.8K | Added |
| 4 | Medtronic PLC | 280.7K | $24.32M | 5.7% | +11.0K | Added |
| 5 | Incyte Corp | 200.5K | $18.87M | 4.5% | −18.3K | Reduced |
| 6 | Amgen Inc | 47.2K | $16.59M | 3.9% | −13.8K | Reduced |
| 7 | Biogen Inc | 90.1K | $16.52M | 3.9% | +4.6K | Added |
| 8 | Zimmer Biomet Holdings Inc | 155.8K | $14.09M | 3.3% | +23.4K | Added |
| 9 | Biomarin Pharmaceutical Inc | 239.9K | $13.55M | 3.2% | +41.4K | Added |
| 10 | Becton Dickinson & Co | 82.6K | $12.99M | 3.1% | −49.8K | Reduced |
32 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio